About this trial
This study will evaluate the impact of a novel non-pharmacological multimodal therapy, a type of approach known to improve pain outcomes and recommended by the Institute of Medicine report for chronic pain management. This study design will also allow the investigators to evaluate a neural model supporting therapeutic alliance for pain outcomes for fibromyalgia.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Meet traditional American College of Rheumatology (ACR) criteria for FM as well as the more recent Wolfe et al 2011 criteria
Are on stable doses of medication for 30 days prior to entering the study and agree not to change medications or dosages during the trial
Ability to fully understand and consent to study procedures
Baseline pain intensity of at least 4/10
Disqualifiers
Any longer period of work experience involving pain treatment, pain rehabilitation etc.
Presence of any illness that is judged to interfere with the trial. For example: psychiatric disorder according to the DSM-IV manual
Presence of any contraindications to fMRI scanning. For example: cardiac pacemaker, metal implants, fear of closed spaces, pregnancy.
History of significant head injury
Trial design
Parallel
Treatments tested in this trial
Electroacupuncture
Other interventionDuring the treatment sessions the acupuncturist will insert needles in several locations aimed to reduce the patient's fibromyalgia pain. A low-amplitude, sub-sensory electrical current will be activated by the acupuncturist.
Cognitive Training
BehavioralCognitive training with a pain specialist.
Education Training
BehavioralEducation training with a pain specialist.
Treatment groups
Trial outcomes
Primary outcomes
Brain Imaging-fMRI
Hyperscan fMRI assessing brain-to-brain concordance between the patient and the clinician.
Secondary outcomes
Brain Imaging-EEG
Hyperscan EEG assessing brain-to-brain concordance between the patient and the clinician.
Other outcomes
Brief Pain Inventory (BPI) - Pain Interference
Brief Pain Inventory (BPI) is a validated 16 item questionnaire designed to assess the severity and interference of pain experienced. Pain interference is assessed on a scale from 0 (no interference) to 10 (severe interference).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Spaulding Rehabilitation Hospital
Lead sponsor
National Institutes of Health (NIH)
Collaborator